Novo Nordisk says Ozempic helped patients with Type 2 diabetes in one new way
Novo Nordisk A.S. said Tuesday a five-year trial of its Ozempic weight-loss drug helped reduce the risk of kidney disease-related...
DK:NOVO.B
Viking Therapeutics’ weight-loss drug data makes company takeover target
Viking Therapeutics Inc.’s stock rose another 8% Wednesday to extend its week-to-date gains to 145%, as analysts weighed in on...
Novo Nordisk’s controlling shareholder to buy Catalent for $16.5 billion
The controlling shareholder of weight-loss drug maker Novo Nordisk on Monday said it’s buying a provider of drug manufacturing for...
Ozempic maker Novo Nordisk reports 62% surge in profit
Novo Nordisk on Wednesday said its fourth-quarter profit surged by nearly two-thirds, driven by the popularity of its weight-loss drugs...
Ozempic parent Novo Nordisk to collaborate with Omega and Cellarity on obesity treatments
Novo Nordisk has entered research collaboration agreements with Omega Therapeutics Inc. and Cellarity Inc. on new treatments for obesity management,...
LifeMD and Medifast to create weight-management program that includes GLP-1 drugs
LifeMD Inc., a virtual primary care provider, said Wednesday it’s teaming up with Medifast Inc. MED, -12.08% to create a...
